Skip to main content

GSR Ventures

By Jessica Hagen | 03:20 pm | October 27, 2023
A GSR Ventures survey revealed 71% of investors believe the tech is changing their investment strategy "somewhat," and 17% say it changes their strategy "significantly."
By Jessica Hagen | 12:26 pm | April 19, 2023
During Venture Connect at HIMSS23, panelists discussed the future of digital therapeutics.
By Emily Olsen | 11:03 am | December 09, 2022
Though funding has fallen this year, Dr. Sunny Kumar, partner at GSR Ventures, said there are still opportunities for startups that can prove their value.
By Jessica Hagen | 04:10 pm | December 02, 2022
A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company's success next year.
By Laura Lovett | 04:32 pm | May 06, 2020
GSR Ventures led the round with participation from sequoia Capital, Storm Ventures, NextGen Venture Partners and BIXINK Therapeutics. 
By Laura Lovett | 04:35 pm | May 04, 2020
This new investment brings the company's total funding to $45 million. 
By Laura Lovett | 12:02 pm | March 06, 2020
GSR Venture US led the round with participation from Arsenal Growth and existing investors.